Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles R Cleland

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 26, 2014
Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool childrenCharles R Cleland, Edridah M Tukahebwa, Alan Fenwick, et al.
Eye (London, England)|May 19, 2022
Gender bias within a diabetic retinopathy screening programme in TanzaniaCharles R Cleland, Cristovao Matsinhe, William U Makupa, et al.
Journal of Ophthalmology|October 13, 2015
The Arclight Ophthalmoscope: A Reliable Low-Cost Alternative to the Standard Direct OphthalmoscopeJames Lowe, Charles R Cleland, Evarista Mgaya, et al.
BMJ Open Diabetes Research & Care|August 2, 2023
Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping reviewCharles R Cleland, Justus Rwiza, Jennifer R Evans, et al.
Tropical Medicine & International Health : TM & IH|December 9, 2015
Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programmeCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 16, 2024
Implementing an artificial intelligence system into a diabetic eye screening programme in TanzaniaCharles R Cleland, William U Makupa, Bernadetha R Shilio, et al.
BMC Ophthalmology|July 21, 2016
Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional studyChristina Mtuya, Charles R Cleland, Heiko Philippin, et al.
Value in Health Regional Issues|June 2, 2026
Quality-of-Life and Utility Values Associated With Diabetic Retinopathy in TanzaniaCharles R Cleland, Anna P Marques, John Cairns, et al.
Plos One|October 7, 2016
Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from TanzaniaJohn W Stanifer, Charles R Cleland, Gerald Jamberi Makuka, et al.
BMJ Open|January 25, 2024
Artificial intelligence-supported diabetic retinopathy screening in Tanzania: rationale and design of a randomised controlled trialCharles R Cleland, Covadonga Bascaran, William Makupa, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 26, 2014
Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool childrenCharles R Cleland, Edridah M Tukahebwa, Alan Fenwick, et al.
Eye (London, England)|May 19, 2022
Gender bias within a diabetic retinopathy screening programme in TanzaniaCharles R Cleland, Cristovao Matsinhe, William U Makupa, et al.
Journal of Ophthalmology|October 13, 2015
The Arclight Ophthalmoscope: A Reliable Low-Cost Alternative to the Standard Direct OphthalmoscopeJames Lowe, Charles R Cleland, Evarista Mgaya, et al.
BMJ Open Diabetes Research & Care|August 2, 2023
Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping reviewCharles R Cleland, Justus Rwiza, Jennifer R Evans, et al.
Tropical Medicine & International Health : TM & IH|December 9, 2015
Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programmeCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 16, 2024
Implementing an artificial intelligence system into a diabetic eye screening programme in TanzaniaCharles R Cleland, William U Makupa, Bernadetha R Shilio, et al.
BMC Ophthalmology|July 21, 2016
Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional studyChristina Mtuya, Charles R Cleland, Heiko Philippin, et al.
Value in Health Regional Issues|June 2, 2026
Quality-of-Life and Utility Values Associated With Diabetic Retinopathy in TanzaniaCharles R Cleland, Anna P Marques, John Cairns, et al.
Plos One|October 7, 2016
Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from TanzaniaJohn W Stanifer, Charles R Cleland, Gerald Jamberi Makuka, et al.
BMJ Open|January 25, 2024
Artificial intelligence-supported diabetic retinopathy screening in Tanzania: rationale and design of a randomised controlled trialCharles R Cleland, Covadonga Bascaran, William Makupa, et al.
Pageof 2